|
| Press Releases |
|
 |
|
| Wednesday, May 8, 2019 |
|
|
Jacobson Pharma and Yunnan Baiyao Group to Continue Exploring Further Possibilities of Business Cooperation and Other Collaborations |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has been informed by Yunnan Baiyao Holdings Company Limited1 ("Baiyao Holdings") and Yunnan Baiyao Group Co.,Ltd. more info >> |
|
| Thursday, May 2, 2019 |
|
|
Jacobson Pharma Issues Positive Profit Alert |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has today announced a positive profit alert. more info >> |
|
| Wednesday, November 21, 2018 |
|
|
Jacobson Pharma Announces FY2019 Interim Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its unaudited interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2018 (the "reporting period").
more info >> |
|
| Monday, June 25, 2018 |
|
|
Jacobson Pharma Announces 2018 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2018 ("FY2018"). more info >> |
|
|
Jacobson Pharma Announces 2018 Annual Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2018 ("FY2018").
more info >> |
|
| Thursday, June 14, 2018 |
|
|
Jacobson Pharma Updates on TAILORx Study |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), the Hong Kong and Macau exclusive distributor of Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests, is pleased to share that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score(R) results of 11 to 25. more info >> |
|
| Wednesday, June 13, 2018 |
|
|
Jacobson Pharma Updates on TAILORx Study |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), the Hong Kong and Macau exclusive distributor of Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests more info >> |
|
| Tuesday, April 17, 2018 |
|
|
Jacobson Pharma Ranked No.1 in "Hong Kong Best Small-Cap Company" in the "Asia's Best Companies Poll 2018" by FinanceAsia |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce that Jacobson Pharma ranked no.1 in the category of Hong Kong Best Small-Cap Company in the "Asia's Best Companies Poll 2018" conducted by FinanceAsia, an authoritative financial magazine in Asia. more info >> |
|
|
Jacobson Pharma Ranked No. 1 in "Hong Kong Best Small-Cap Company" in the "Asia's Best Companies Poll 2018" by FinanceAsia |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce that Jacobson Pharma ranked no.1 in the category of Hong Kong Best Small-Cap Company in the "Asia's Best Companies Poll 2018" conducted by FinanceAsia, an authoritative financial magazine in Asia. more info >> |
|
| Wednesday, December 20, 2017 |
|
|
Jacobson Pharma Enters Agreements with Shanghai Henlius Biotech Inc. To Tap Biologics Market |
| Jacobson Pharma Corporation Limited today announced that through its wholly-owned subsidiaries, Jacobson Medical (Hong Kong) Limited and Joyful Ascent Limited, it has entered into a Licensing Framework Agreement and a Capital Increase Agreement with a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. namely, Shanghai Henlius Biotech Inc., a technological leader in research and development of biosimilar antibody drugs in China. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Announcing Zion Shores
Apr 18, 2025 23:06 HKT/SGT
|
|
|
FXSpire Debuts in Dubai as Forex Traders Seek Smarter Tools Amid Global Uncertainty
Apr 18, 2025 21:00 HKT/SGT
|
|
|
FXiBot Launches with a Precision Strategy for GBP/USD Trading
Apr 18, 2025 20:00 HKT/SGT
|
|
|
Fujitsu Kozuchi AI technologies assist AKOS AI in delivering solutions for EU AI compliance
Apr 18, 2025 17:41 JST
|
|
|
Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union
Apr 18, 2025 16:52 JST
|
|
|
Hitachi Industrial Equipment Systems Launches Next-Generation Inverter System to Support Stable, Resilient Power Grids
Apr 18, 2025 16:46 JST
|
|
|
Thailand's Brewing Industry Gets a Boost with Life Below Labs' Local Yeast Hub
Apr 18, 2025 13:15 HKT/SGT
|
|
|
A Strategic Event for HR Leaders and Experts to Drive Transformation in the Saudi Workforce
Apr 18, 2025 10:22 HKT/SGT
|
|
|
PerfectSwell(R) Zion To Start Construction
Apr 17, 2025 19:00 HKT/SGT
|
|
|
OMP Positioned Highest for Ability to Execute in the 2025 Gartner(R) Magic Quadrant(TM) for Supply Chain Planning Solutions
Apr 17, 2025 17:00 HKT/SGT
|
|
|
Under the patronage of Maktoum bin Mohammed DIFC to host 3rd edition of Dubai FinTech Summit on 12-13 May 2025
Apr 17, 2025 15:26 HKT/SGT
|
|
|
MHIEC Receives Order from the Bureau of Sewerage of the Tokyo Metropolitan Government for Rebuilding of Sewage Sludge Incineration Facility
Apr 17, 2025 14:44 JST
|
|
|
Fiskl and Airwallex Transform SME Finance with AI 
Apr 17, 2025 12:30 HKT/SGT
|
|
|
Fujitsu collaboration with Supermicro and Nidec to reduce data center energy consumption
Apr 17, 2025 10:32 JST
|
|
|
CBL International Limited Reports 2024 Full-Year Results
Apr 17, 2025 09:17 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
